It looks like you're new here. If you want to get involved, click one of these buttons!
I'm 100% with you here. It seems like you are starting with this and backing into "solutions" that make no sense, in part because you're tying ERs (and other SEC disclosures) to taxes when those are two different (though related) things, calculated in ways that don't always line up.
Think that this sort of information should be disclosed by the funds for benefit of shareholders that don't have the time or resources to gather the information and calculate the numbers themselves.
Ticker Div Yield Foreign Tax Paid Expense Ratio Div Yield x Forgn Tax Pd
VTRIX 2.72% 4.94% 0.44% 0.13%
VFWAX 2.99% 5.33% 0.14% 0.16%
VGRLX 3.22% 4.66% 0.24% 0.15%
The "unclaimable" foreign tax credit (for investors who hold the funds in tax -advantaged retirement accounts) appears in the last column of the above table, and is equal to the product of the [Dividend Yield] and [Foreign Tax Paid].How is that any different from holding a fund with a higher expense ratio, rather than a lower expense ratio? Could I, for example, say the following with a straight face?:Think of it as a timing issue: The amount you pay in foreign taxes today reduces your retirement assets, and therefore reduces the amount of tax the IRS is able to collect when you start making withdrawals.
Which is precisely my point.Think of it as a timing issue: The amount you pay in higher expensesforeign taxestoday reduces your retirement assets, and therefore reduces the amount of tax the IRS is able to collect when you start making withdrawals.
Per the article: "I haven't listed any target-date funds. We have customized target-date funds designed specifically for Morningstar employees by Ibbotson Associates, which is part of the Morningstar Investment Management group."Expense ratios are kind of high.
I also don't see any sort of "target date" funds, which I thought had some sort of special "safe harbor" treatment as a default investment, but perhaps I am "mis-remembering" this preference given to "target date" funds in a 401k.
1% ER's in a 401K? .....
And, gotta love (not) this...“Of course, the problem is much bigger than this one case,” said Barbara Roper, director of investor protection at the Consumer Federation of America. “The S.E.C. has allowed 12b-1 fees to morph into distribution fees when they were originally intended to serve a very different purpose. The agency had a reform proposal ready to go back in the early days of this administration, but the industry didn’t like it, so it never went anywhere.”
There are signs, however, that the First Eagle case may be just the initial S.E.C. salvo on improper mutual fund fee practices. Tricks involving 12b-1 fees are a rich vein for the S.E.C. to mine because these charges are exceedingly opaque. Bringing cases in this area is crucial for investors since these fees drag down fund returns.
These fees also pose real conflicts of interest. Investment advisers are paid based on a percentage of assets under management; as these assets grow, so does the adviser’s income. Marketing a fund helps increase assets under management, so the investment adviser is the primary beneficiary of any fees paid for that purpose.
First Eagle’s website contains a list of its guiding principles. This is one of them: “Always act with honesty, integrity and transparency. Never have anything to hide.”
Celgene (CELG) and Gilead (GILD) are the primary two that I have as long-term holdings. Amgen (AMGN) is also worth a look at these levels. Celgene has basically given investors guidance out to 2020 and while it's not a major part of their revenue, Celgene is interesting from the standpoint of you have a biotech that basically is picking and choosing what it believes are compelling possible collaborations in a lot of the smaller (and some larger names.)let us know what's on your list, okay?

© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla